Connecting Type 1 and Type 2 Diabetes through Innate Immunity
- 1Department of Pathology, Stanford University School of Medicine, Stanford, California 94305
- 2Cardiovascular Research Institute, Department of Physiology, and Department of Medicine, University of California, San Francisco, San Francisco, California 94158
- Correspondence: ajay.chawla{at}ucsf.edu
Abstract
The escalating epidemic of obesity has driven the prevalence of both type 1 and 2 diabetes mellitus to historically high levels. Chronic low-grade inflammation, which is present in both type 1 and type 2 diabetics, contributes to the pathogenesis of insulin resistance. The accumulation of activated innate immune cells in metabolic tissues results in release of inflammatory mediators, in particular, IL-1β and TNFα, which promote systemic insulin resistance and β-cell damage. In this article, we discuss the central role of innate immunity and, in particular, the macrophage in insulin sensitivity and resistance, β-cell damage, and autoimmune insulitis. We conclude with a discussion of the therapeutic implications of this integrated understanding of diabetic pathology.
- Copyright © 2012 Cold Spring Harbor Laboratory Press; all rights reserved